LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

BARCLAYS PLC's Holding History (CIK: 0000312069)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 240,615 Value ($000) $332 Avg Close — Range —
Q1 2025
Shares 183,467 Value ($000) $99 Avg Close — Range —
Q4 2024
Shares 258,380 Value ($000) $165 Avg Close — Range —
Q3 2024
Shares 240,615 Value ($000) $0 Avg Close — Range —
Q2 2024
Shares 58,300 Value ($000) $85 Avg Close — Range —
Q1 2024
Shares 146,541 Value ($000) $327 Avg Close — Range —
Q4 2023
Shares 263,070 Value ($000) $510 Avg Close — Range —
Q3 2023
Shares 245,243 Value ($000) $361 Avg Close — Range —
Q2 2023
Shares 198,268 Value ($000) $1 Avg Close — Range —
Q1 2023
Shares 245,251 Value ($000) $1 Avg Close — Range —
Q4 2022
Shares 335,408 Value ($000) $1 Avg Close — Range —
Q3 2022
Shares 134,708 Value ($000) $988 Avg Close — Range —
Q2 2022
Shares 8,684 Value ($000) $57 Avg Close — Range —
Q1 2022
Shares 32,639 Value ($000) $164 Avg Close — Range —